|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Adherex Technologies Inc., of Ottawa, Ontario, said CEO John Brooks acquired an additional 1 million company shares. Of the total, 925,000 are by transfer of escrow and the remaining 75,000 shares were purchased through the Toronto Stock Exchange. Brooks now owns or controls nearly 4 million common shares, or 9.9 percent of the company. He also holds options for the right to purchase up to 720,000 common shares exercisable until 2007.
Biacore AB, of Uppsala, Sweden, said the Reverse Proteomics Research Institute Co. Ltd., a consortium of 11 Japanese companies involved with pharmaceutical development, invested in its Biacore S51. Its sensitivity and ...